The anti-infective drug market is seeing strong growth due to multiple interrelated factors. One key driver is the rising incidence of specific infectious diseases, including healthcare-associated ...

Last year, GSK said it was planning to invest a cool £1 billion in infectious diseases, with an emphasis on neglected tropical diseases and antimicrobial resistance (AMR). Now, its spent some of ...

Antimicrobial resistance is among the most significant threats to public health and development, says WHO Recce Pharmaceuticals is tackling the global health problem of antibiotic-resistant superbugs ...

Sep. 18, 2024 — Researchers found that a medicine called ferric carboxymaltose given in drip through the vein works faster and better than an iron tablet taken by mouth for the treatment of ...

Impact and progress Frontiers' impact Progress Report 2022 All progress reports ...

Mechanisms of drug action explored through proteomics and transcriptomics research • In-depth validation of disease targets beyond initial analysis, including signaling pathway and pharmacological ...

Erdosteine is a multimechanism, mucolytic agent that decreases the sputum viscoelastic properties and bacterial adhesion to the cell membrane, endowed with bronchial anti-inflammatory activity and ...

We may earn commission on some of the items you choose to buy. Of course, results from anti-aging serums “may vary depending on factors like formulation, stability, ingredients, and individual ...

Pharmacology is a branch of biomedical science ... secondary gene networks that drive myeloid cell differentiation. The anti-apoptotic protein MCL1 is a therapeutic target in cancer, but long ...

“Major pharmaceutical companies have exited the anti-infective R&D space over the last 15 years driving pharma investments and technical know-how into other areas,” explained Mark ...